Concepts (205)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Genetic Vectors | 22 | 2016 | 1694 | 1.900 |
Why?
|
| Adenoviruses, Human | 8 | 2013 | 181 | 1.260 |
Why?
|
| Adenoviridae | 21 | 2016 | 1459 | 1.220 |
Why?
|
| Capsid Proteins | 8 | 2010 | 185 | 0.960 |
Why?
|
| Genetic Therapy | 18 | 2016 | 1616 | 0.900 |
Why?
|
| Gene Targeting | 6 | 2010 | 292 | 0.800 |
Why?
|
| Gene Transfer Techniques | 11 | 2013 | 716 | 0.450 |
Why?
|
| Transduction, Genetic | 5 | 2007 | 475 | 0.420 |
Why?
|
| Genetic Engineering | 2 | 2003 | 288 | 0.400 |
Why?
|
| Adenoviruses, Simian | 1 | 2010 | 4 | 0.380 |
Why?
|
| Capsid | 3 | 2009 | 103 | 0.290 |
Why?
|
| CD40 Antigens | 2 | 2003 | 104 | 0.280 |
Why?
|
| Disulfides | 1 | 2003 | 116 | 0.230 |
Why?
|
| DNA, Viral | 2 | 2010 | 694 | 0.200 |
Why?
|
| Virion | 3 | 2010 | 161 | 0.190 |
Why?
|
| Cell Line | 7 | 2009 | 5114 | 0.170 |
Why?
|
| Ligands | 4 | 2007 | 995 | 0.170 |
Why?
|
| Oligopeptides | 4 | 2005 | 429 | 0.170 |
Why?
|
| Receptors, Virus | 6 | 2005 | 157 | 0.160 |
Why?
|
| Luciferases | 4 | 2010 | 445 | 0.150 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 121 | 0.150 |
Why?
|
| Virus Replication | 6 | 2005 | 709 | 0.130 |
Why?
|
| Ankyrin Repeat | 2 | 2013 | 15 | 0.130 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 2 | 2004 | 215 | 0.110 |
Why?
|
| Recombinant Fusion Proteins | 5 | 2009 | 1555 | 0.110 |
Why?
|
| Protein Engineering | 1 | 2013 | 100 | 0.110 |
Why?
|
| Receptor, ErbB-2 | 3 | 2013 | 2518 | 0.110 |
Why?
|
| Serotyping | 2 | 2010 | 166 | 0.110 |
Why?
|
| Recombinant Proteins | 4 | 2013 | 2927 | 0.100 |
Why?
|
| Isoenzymes | 2 | 2004 | 614 | 0.100 |
Why?
|
| Tumor Cells, Cultured | 9 | 2003 | 5395 | 0.100 |
Why?
|
| Mice | 15 | 2016 | 34495 | 0.100 |
Why?
|
| Ice Cover | 1 | 2010 | 4 | 0.100 |
Why?
|
| Viral Tropism | 1 | 2010 | 40 | 0.100 |
Why?
|
| Factor X | 1 | 2010 | 10 | 0.100 |
Why?
|
| ErbB Receptors | 2 | 2011 | 2295 | 0.090 |
Why?
|
| Kupffer Cells | 1 | 2010 | 42 | 0.090 |
Why?
|
| Base Sequence | 2 | 2010 | 4917 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 234 | 0.090 |
Why?
|
| Animals | 17 | 2016 | 59536 | 0.090 |
Why?
|
| Single-Chain Antibodies | 1 | 2009 | 62 | 0.090 |
Why?
|
| Species Specificity | 1 | 2010 | 777 | 0.080 |
Why?
|
| Molecular Imaging | 1 | 2011 | 185 | 0.080 |
Why?
|
| DNA Primers | 1 | 2010 | 1399 | 0.080 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2008 | 90 | 0.080 |
Why?
|
| Integrins | 3 | 2005 | 262 | 0.080 |
Why?
|
| Cell Line, Tumor | 8 | 2013 | 14551 | 0.080 |
Why?
|
| Dendritic Cells | 2 | 2004 | 1085 | 0.080 |
Why?
|
| Genes, Viral | 2 | 2005 | 202 | 0.070 |
Why?
|
| Immunoglobulin Fragments | 2 | 2003 | 28 | 0.070 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 5 | 2005 | 38 | 0.070 |
Why?
|
| Humans | 28 | 2016 | 261506 | 0.070 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 541 | 0.070 |
Why?
|
| Liver | 2 | 2010 | 2961 | 0.070 |
Why?
|
| Ribonucleoproteins, Small Nuclear | 1 | 2005 | 43 | 0.070 |
Why?
|
| Mice, Nude | 7 | 2011 | 4307 | 0.060 |
Why?
|
| Staphylococcal Protein A | 1 | 2003 | 18 | 0.060 |
Why?
|
| Bacteriophage T4 | 1 | 2003 | 7 | 0.060 |
Why?
|
| Viral Proteins | 2 | 2003 | 435 | 0.060 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 1320 | 0.060 |
Why?
|
| Ovarian Neoplasms | 4 | 2005 | 4638 | 0.060 |
Why?
|
| Herpesvirus 1, Human | 1 | 2004 | 113 | 0.060 |
Why?
|
| Cytokines | 2 | 2010 | 2809 | 0.060 |
Why?
|
| CD40 Ligand | 1 | 2003 | 115 | 0.060 |
Why?
|
| Transfection | 3 | 2004 | 2944 | 0.060 |
Why?
|
| Adenoviridae Infections | 1 | 2003 | 125 | 0.060 |
Why?
|
| Protein Binding | 4 | 2013 | 3438 | 0.060 |
Why?
|
| Receptors, Vitronectin | 1 | 2002 | 24 | 0.060 |
Why?
|
| Hepatitis C Antibodies | 1 | 2002 | 41 | 0.050 |
Why?
|
| Viral Envelope Proteins | 1 | 2004 | 207 | 0.050 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2005 | 467 | 0.050 |
Why?
|
| Gamma Cameras | 1 | 2002 | 40 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 6 | 2005 | 3101 | 0.050 |
Why?
|
| Receptors, Somatostatin | 1 | 2002 | 85 | 0.050 |
Why?
|
| Binding, Competitive | 3 | 2011 | 300 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 193 | 0.050 |
Why?
|
| Cricetinae | 1 | 2002 | 706 | 0.050 |
Why?
|
| Enterovirus | 1 | 2002 | 63 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 6942 | 0.050 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2002 | 163 | 0.050 |
Why?
|
| Peptides | 2 | 2009 | 1479 | 0.050 |
Why?
|
| Neoplasms | 1 | 2007 | 15193 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 4233 | 0.050 |
Why?
|
| Lung Neoplasms | 5 | 2011 | 11538 | 0.050 |
Why?
|
| Tropism | 1 | 2000 | 19 | 0.050 |
Why?
|
| Cell Membrane | 1 | 2004 | 850 | 0.050 |
Why?
|
| Blotting, Western | 4 | 2011 | 3536 | 0.050 |
Why?
|
| Virus Assembly | 1 | 2000 | 51 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2009 | 6089 | 0.050 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 1390 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 4971 | 0.040 |
Why?
|
| Molecular Structure | 1 | 2000 | 515 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1506 | 0.040 |
Why?
|
| Bile Duct Neoplasms | 1 | 2003 | 493 | 0.040 |
Why?
|
| Cholangiocarcinoma | 1 | 2003 | 493 | 0.040 |
Why?
|
| Cyclooxygenase 2 | 3 | 2005 | 483 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2002 | 524 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2011 | 5319 | 0.040 |
Why?
|
| Gene Dosage | 1 | 2000 | 829 | 0.040 |
Why?
|
| Genes, Reporter | 3 | 2004 | 798 | 0.040 |
Why?
|
| Apoptosis | 3 | 2008 | 7591 | 0.040 |
Why?
|
| Epitopes | 2 | 2009 | 685 | 0.030 |
Why?
|
| Stomach Neoplasms | 2 | 2005 | 2278 | 0.030 |
Why?
|
| Plasmids | 1 | 1996 | 837 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2004 | 7789 | 0.030 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2005 | 187 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2011 | 3821 | 0.030 |
Why?
|
| Protein Structure, Quaternary | 1 | 2013 | 138 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2005 | 3033 | 0.030 |
Why?
|
| Adenovirus E1A Proteins | 2 | 2004 | 163 | 0.030 |
Why?
|
| Luminescent Proteins | 2 | 2004 | 289 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2004 | 4053 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2008 | 1519 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2008 | 8873 | 0.030 |
Why?
|
| Myocardium | 1 | 1998 | 1313 | 0.030 |
Why?
|
| Female | 10 | 2010 | 141928 | 0.030 |
Why?
|
| Transcription, Genetic | 3 | 2005 | 3154 | 0.030 |
Why?
|
| Radiopharmaceuticals | 2 | 2011 | 1301 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2004 | 694 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2013 | 627 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 2004 | 568 | 0.020 |
Why?
|
| HeLa Cells | 2 | 2005 | 1643 | 0.020 |
Why?
|
| Technetium | 2 | 2002 | 77 | 0.020 |
Why?
|
| Esophageal Neoplasms | 1 | 2004 | 3168 | 0.020 |
Why?
|
| Peptide Library | 1 | 2010 | 158 | 0.020 |
Why?
|
| Leucine Zippers | 1 | 2009 | 39 | 0.020 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2002 | 2326 | 0.020 |
Why?
|
| RNA, Messenger | 3 | 2004 | 6150 | 0.020 |
Why?
|
| Amino Acid Substitution | 1 | 2011 | 644 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2009 | 240 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2013 | 1489 | 0.020 |
Why?
|
| Kidney Neoplasms | 1 | 2002 | 3022 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2009 | 699 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2013 | 1732 | 0.020 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2008 | 119 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 196 | 0.020 |
Why?
|
| Lung | 1 | 1998 | 3151 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2008 | 471 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2013 | 1203 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5061 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2002 | 2307 | 0.020 |
Why?
|
| Quinazolines | 1 | 2011 | 923 | 0.020 |
Why?
|
| Time Factors | 3 | 2004 | 12926 | 0.020 |
Why?
|
| Gastrin-Releasing Peptide | 1 | 2005 | 6 | 0.020 |
Why?
|
| Proteinase Inhibitory Proteins, Secretory | 1 | 2005 | 20 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2011 | 1226 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 342 | 0.020 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2005 | 60 | 0.020 |
Why?
|
| Adenovirus E2 Proteins | 1 | 2004 | 3 | 0.020 |
Why?
|
| Artificial Gene Fusion | 1 | 2004 | 18 | 0.020 |
Why?
|
| Gastrointestinal Agents | 1 | 2005 | 108 | 0.020 |
Why?
|
| Heparitin Sulfate | 1 | 2004 | 35 | 0.020 |
Why?
|
| Gene Expression | 2 | 2003 | 3570 | 0.020 |
Why?
|
| Adenovirus E1 Proteins | 1 | 2003 | 4 | 0.010 |
Why?
|
| Lac Operon | 1 | 2004 | 122 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 2005 | 227 | 0.010 |
Why?
|
| Helper Viruses | 1 | 2004 | 55 | 0.010 |
Why?
|
| Vero Cells | 1 | 2004 | 143 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 383 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2004 | 96 | 0.010 |
Why?
|
| Temperature | 1 | 2005 | 506 | 0.010 |
Why?
|
| Ribosomes | 1 | 2004 | 147 | 0.010 |
Why?
|
| Membrane Proteins | 2 | 2004 | 2819 | 0.010 |
Why?
|
| Chimera | 1 | 2003 | 145 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 2002 | 66 | 0.010 |
Why?
|
| Arabinofuranosyluracil | 1 | 2002 | 42 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 5637 | 0.010 |
Why?
|
| Transgenes | 1 | 2004 | 557 | 0.010 |
Why?
|
| Herpesviridae | 1 | 2002 | 42 | 0.010 |
Why?
|
| Positron-Emission Tomography | 1 | 2011 | 2173 | 0.010 |
Why?
|
| Oncolytic Virotherapy | 1 | 2005 | 280 | 0.010 |
Why?
|
| Kidney | 1 | 2010 | 2146 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 1489 | 0.010 |
Why?
|
| Antibodies | 1 | 2005 | 838 | 0.010 |
Why?
|
| Spheroids, Cellular | 1 | 2002 | 222 | 0.010 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2003 | 334 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2003 | 613 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2004 | 1487 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2002 | 351 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2003 | 703 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 750 | 0.010 |
Why?
|
| Iodine Radioisotopes | 1 | 2002 | 371 | 0.010 |
Why?
|
| Glycoproteins | 1 | 2004 | 747 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 2005 | 2314 | 0.010 |
Why?
|
| Cytomegalovirus | 1 | 2003 | 482 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 2084 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 1688 | 0.010 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2005 | 1533 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2011 | 7226 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2002 | 1869 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1998 | 521 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2003 | 1620 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1998 | 573 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 1998 | 660 | 0.010 |
Why?
|
| Proteins | 1 | 2005 | 1963 | 0.010 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 4757 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2011 | 7551 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2004 | 2488 | 0.010 |
Why?
|
| Mutation | 1 | 2011 | 15179 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2002 | 2027 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 1998 | 4938 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 4367 | 0.010 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2003 | 5437 | 0.000 |
Why?
|
| Antineoplastic Agents | 1 | 2008 | 14289 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2005 | 15694 | 0.000 |
Why?
|